OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
November 15, 2016
Pressures to accelerate current and next-gen therapies are challenging traditional microbiological testing models.
November 10, 2016
Dedicated facility will address enhanced regulation of metals and impurities in pharmaceuticals.
November 08, 2016
Idifarma has announced a growth of more than 50% over the past two years. Revenue is expected to hit approximately EUR5.3 million in 2016, growing from EUR3.5 million in 2014.
November 04, 2016
The new facility will focus on formulation development, drug product analytical development, and quality control.
November 02, 2016
CMO executives are focusing on M&A activity, new business models, and fundraising limits.
Recipharm is investing more than EUR1.2 million to enhance its small-scale GMP API development and manufacturing capabilities in Paderno Dugnano, Italy.
October 24, 2016
Catalent invests $34 million to add a 2 x 2000-L single-use bioreactor system and laboratory space in Madison, WI.
October 02, 2016
This key bioprocessing segment is expecting continued growth
September 21, 2016
The company announced that an August 2016 FDA inspection of the company’s facility resulted in no form 483s.
September 12, 2016
Saneca Pharma is making significant investment in its API capabilities to support client demand for smaller batch sizes and streamlined scale-up.